Hospitalization for vasa previa: a review of national guidelines

Routine antenatal hospitalization for prenatally diagnosed vasa previa (VP) has become common practice in many centers to facilitate close surveillance and rapid cesarean delivery in the event of labor or membrane rupture. However, the evidentiary basis for this approach remains limited, and it is unclear whether national obstetric society guidelines uniformly endorse routine admission or recommend individualized management.

To review and compare national and international obstetric society guidelines addressing VP and to evaluate their recommendations regarding antenatal hospitalization, including the strength and evidence base of these recommendations.

We conducted a comparative guideline analysis of 5 publicly available national VP guidelines: Nordic Federation of Societies of Obstetrics and Gynecology (NFOG), Royal College of Obstetricians and Gynecologists (RCOG), Society for Maternal-Fetal Medicine (SMFM), Society of Obstetricians and Gynecologists of Canada (SOGC), and the Royal Australian and New Zealand College of Obstetricians and Gynecologists (RANZCOG). Guidelines were evaluated for explicit recommendations on routine antenatal hospitalization, options for outpatient management, recommendations for hospitalization of symptomatic patients or those with risk factors for preterm birth and suggested gestational age for hospitalization. The evidence supporting these recommendations was also assessed.

None of the 5 guidelines explicitly recommend routine hospitalization, and all emphasize the limited evidence supporting this practice. Only the Society of Obstetricians and Gynecologists of Canada (SOGC) suggests considering hospitalization for all patients with VP, while acknowledging that this recommendation remains controversial and largely based on expert opinion rather than robust data. All guidelines recommend considering hospitalization for symptomatic patients or those at high risk for preterm birth. Suggested gestational ages for consideration of antenatal hospitalization ranged from 30 to 34 weeks. All but 1 guideline (SOGC) rated the strength of evidence for inpatient or outpatient management as "limited" or "weak."

National obstetric organizations do not explicitly recommend routine antenatal hospitalization for all patients with VP; however, none discourage hospitalization when clinically indicated. All guidelines acknowledge limited supporting evidence and emphasize individualized management based on patient risk factors, preferences, and access to appropriate maternal and neonatal care.